Articles tagged with: ASH 2012 Meeting

News»

[ by | Updated: Dec 16, 2012 7:00 pm | 10 Comments ]
ASH 2012 Multiple Myeloma Update – Day Three: Early Morning Oral Session

Today is the third day of the American Society of Hematology (ASH) 2012 annual meeting in Atlanta, and it is packed full with multiple myeloma-related presentations. Presentations started early in the morning and will continue through the afternoon.

Over the course of today, at least 11 different oral sessions, many of which are being held simultaneously, will include presentations about myeloma-related topics.  The Beacon will summarize presentations from the four most relevant sessions in updates such as this one.  This update, in particular, covers presentations from the first of those …

Read the full story »

News»

[ by | Dec 10, 2012 1:18 pm | One Comment ]
ASH 2012 Multiple Myeloma Update – Day Two: Poster Sessions

Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting.  Although the myeloma-related sessions got a bit of a late start, the day featured a wide range of interesting presentations about multiple myeloma.

Many myeloma-related oral presentations were given in the afternoon and were summarized in updates published yesterday and earlier today.

During the evening yesterday, a poster session took place where important new research findings were summarized in posters displayed throughout a large conference hall. The studies covered a variety of myeloma-related …

Read the full story »

News»

[ by | Updated: Dec 16, 2012 6:40 pm | 6 Comments ]
ASH 2012 Multiple Myeloma Update – Day Two: Late Afternoon Oral Session

Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting, which is being held in Atlanta.

The day’s myeloma-related presentations began in the afternoon with three sessions of oral presentations.  Two of the sessions focused on results from clinical trials, most of which studied drugs that are still being developed for the treatment of multiple myeloma.  The third session, which focused on the biology of myeloma, ran simultaneously with one of the sessions about clinical trial results.

An update published yesterday evening summarized the results …

Read the full story »

News»

[ by | Updated: Dec 16, 2012 7:45 pm | 5 Comments ]
ASH 2012 Multiple Myeloma Update – Day Two: Early Afternoon Oral Session

This year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta, began yesterday and goes through Tuesday.

Today’s myeloma-related presentations began this afternoon with three sessions of oral presentations.  Two of the sessions focused on results from clinical trials, most of which studied drugs that are still under development as potential treatments for multiple myeloma.  The third session, which focused on the biology of myeloma, ran simultaneously with one of the sessions about clinical trial results.

This article will summarize the first oral session about multiple …

Read the full story »

News»

[ by | Dec 9, 2012 6:50 am | 2 Comments ]
ASH 2012 Multiple Myeloma Update – Day One: Poster Sessions

Yesterday was the first day of research presentations at this year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta.

Research findings related to multiple myeloma was presented in three different sessions during the day.

Two of the sessions were actually the same general educational session about multiple myeloma, repeated at two different times during the day. The Beacon will cover the presentations given during those sessions in a separate daily update.

The key myeloma-related research presented yesterday, however, was made public during a poster session …

Read the full story »